{"disease":{"id":"lysosomal-disease","name":"lysosomal disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05368038","title":"ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100000,"lead_sponsor_name":"Albert Einstein College of Medicine","has_results":false},{"nct_id":"NCT04393701","title":"A Pilot Study for Systematic Neonatal Screening for Lysosomal Storage Diseases Using Tandem Mass Spectrometry","phase":"NA","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"University Hospital, Rouen","has_results":false},{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT00001215","title":"Genetic Studies of Lysosomal Storage Disorders","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1000,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT00001671","title":"The Classification and Cause of Leukodystrophies of Unknown Cause","phase":"","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false},{"nct_id":"NCT00046202","title":"Study of Inborn Errors of Cholesterol Synthesis and Related Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":342,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":false},{"nct_id":"NCT01633489","title":"Lysosomal Acid Lipase (LAL) Deficiency Registry","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT02416661","title":"Lyso-Gb1 as a Long-term Prognostic Biomarker in Gaucher Disease","phase":"","overall_status":"COMPLETED","enrollment_count":299,"lead_sponsor_name":"CENTOGENE GmbH Rostock","has_results":false},{"nct_id":"NCT07494058","title":"A Study of Home vs Hospital Treatment in People With Fabry, Gaucher or Hunter Conditions in Mexico","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":222,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT04943991","title":"Fabry Disease in High-risk Patients With Left Ventricular Hypertrophy: Prevalence and Implementation of a Clinical Score","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Wuerzburg University Hospital","has_results":false},{"nct_id":"NCT03893240","title":"Neutralizing Antibody Seroprevalence Study With a Retrospective Component in Participants With Late-Onset Pompe Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Spark Therapeutics, Inc.","has_results":false},{"nct_id":"NCT04399694","title":"Identification and Characterization of Novel Non-Coding Variants That Contribute to Genetic Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT03952637","title":"A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":54,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT05431127","title":"High Dose Inspiratory Muscle Training in LOPD","phase":"NA","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT06130228","title":"Nutritional Therapy in Late-onset Pompe Disease","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":28,"lead_sponsor_name":"McMaster University","has_results":false},{"nct_id":"NCT01560182","title":"Gene Therapy for Metachromatic Leukodystrophy (MLD)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Orchard Therapeutics","has_results":false},{"nct_id":"NCT03392987","title":"A Safety and Efficacy Study of Cryopreserved OTL-200 for Treatment of Metachromatic Leukodystrophy (MLD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Orchard Therapeutics","has_results":false},{"nct_id":"NCT01371825","title":"Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Sebelipase Alfa in Children With Growth Failure Due to Lysosomal Acid Lipase Deficiency","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT03853876","title":"A Natural History Study of Aspartylglucosaminuria","phase":"","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"Neurogene Inc.","has_results":false},{"nct_id":"NCT04283227","title":"OTL-200 in Patients With Late Juvenile Metachromatic Leukodystrophy (MLD)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":6,"lead_sponsor_name":"Orchard Therapeutics","has_results":false},{"nct_id":"NCT03897361","title":"Stem Cell Gene Therapy for Cystinosis","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"University of California, San Diego","has_results":false},{"nct_id":"NCT04455230","title":"A Long Term Follow-Up Study of Fabry Disease Subjects Treated With FLT190","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":3,"lead_sponsor_name":"Spur Therapeutics","has_results":false},{"nct_id":"NCT04040049","title":"A Fabry Disease Gene Therapy Study","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"Spur Therapeutics","has_results":false},{"nct_id":"NCT02363153","title":"Diet and Exercise in Pompe Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":2,"lead_sponsor_name":"University of Florida","has_results":false},{"nct_id":"NCT01963650","title":"Natural History Study of Children With Metachromatic Leukodystrophy","phase":"","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Shire","has_results":false},{"nct_id":"NCT04189601","title":"Complement Activation in the Lysosomal Storage Disorders","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Melbourne Health","has_results":false},{"nct_id":"NCT01458613","title":"Biomarker for Maroteaux-Lamy Disease (BioMaroteaux)","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"CENTOGENE GmbH Rostock","has_results":false}],"total":28},"guidelines":[],"source":"Drug Landscape verified database"}